Booth No. : A31
Presentation Representative : Masaru Tomita
Person in Charge of the Project : Mayuko Takatou
Muscular dystrophy is a neuromuscular disorder that causes muscle weakness and hypotonia, hence it is known as a remediless rare disease. This research takes advantage of the leading-edge Metabolome analysis technologies, and aims to develop drugs for treatment, since development of medical treatments and supplies against rare diseases can not advance at a quick pace. We are conducting comprehensive metabolic analysis and are analyzing amino acids and fatty acids contained in the tissues of a muscular dystrophy model mouse, to clarify novel pathogenetic mechanisms.